Market Cap 24.35M
Revenue (ttm) 0.00
Net Income (ttm) -17.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 134,500
Avg Vol 130,032
Day's Range N/A - N/A
Shares Out 12.78M
Stochastic %K 18%
Beta 2.30
Analysts Strong Sell
Price Target $25.00

Company Profile

Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1a clinical trial for the treatment of advanced or metastatic solid tumors, or unresectable or recurrent GBM, solid tumor, such as pancreatic, breast, bladder, and lung cancers, as well as glioblastoma and other central ner...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 277 1136
Address:
1920 McKinney Avenue, 7th Floor, Dallas, United States
BioTechHealthX
BioTechHealthX Sep. 6 at 6:24 PM
$ABSI $LTRN $RXRX $SDGR $SOPH Discover 10 affordable medical AI stocks using artificial intelligence to transform drug development, cancer detection, diagnostics and patient care. https://biotechhealthx.com/biotech-news/10-best-cheap-ai-medicine-stocks-to-buy-now/
0 · Reply
AtariLynx
AtariLynx Sep. 6 at 11:39 AM
$LTRN LET’S GO LANTERN PHARMA! https://youtu.be/CTXYBZXHIzk?is=ZxfxoklIYoiKTUSV
1 · Reply
focafoca99
focafoca99 Sep. 5 at 9:42 PM
$LTRN will be featured on New to The Street broadcast at 6:30 PM ET on Sep 5.
0 · Reply
AtariLynx
AtariLynx Sep. 4 at 8:04 PM
$LTRN closed green. Now green until 2027 😀💪🏻
1 · Reply
AtariLynx
AtariLynx Sep. 4 at 3:28 PM
$LTRN nooooo! I was there when it dropped to 1.19 and no one spoke about R/S. We were all confident that it would rise again and so it did.
1 · Reply
BabetteCH
BabetteCH Sep. 4 at 2:19 PM
$LTRN let‘s reverse-split 🤣
0 · Reply
BabetteCH
BabetteCH Sep. 4 at 7:25 AM
$LTRN @AtariLynx ask him why mgmt does not invest with own money? Not buy open market shares? Thks. 😉
1 · Reply
AtariLynx
AtariLynx Sep. 4 at 7:22 AM
$LTRN I spoke to him again. He said tell Babette that a successful CEO must be prepared and integrated in all areas. He should talk about sports, engines, cookies, travelling, matters of the heart etc etc with the same ease he uses to speak about Lantern’s projects. I'm sure he won't disappoint us!
0 · Reply
BabetteCH
BabetteCH Sep. 4 at 5:27 AM
$LTRN @AtariLynx he didn‘t have time for you, he had to do a new interview with „new to the street“, with words like „could“, „think“, „propably“ - same bs as every time. And on top he had to like EVERY LinkedIn post in the world! So no time for you and business/BP-Deals…
0 · Reply
DarthVestor
DarthVestor Sep. 4 at 12:02 AM
$LTRN pOS stock. POS CEO.
0 · Reply
Latest News on LTRN
Lantern Pharma reports Q2 EPS (57c) vs (40c) last year

2026-08-16T13:37:01.000Z - 22 days ago

Lantern Pharma reports Q2 EPS (57c) vs (40c) last year


Lantern Pharma Earnings Call Transcript: Q2 2026

Aug 14, 2026, 9:00 AM EDT - 24 days ago

Lantern Pharma Earnings Call Transcript: Q2 2026


Lantern Pharma Quarterly report: Q2 2026

Aug 14, 2026, 9:00 AM EDT - 24 days ago

Lantern Pharma Quarterly report: Q2 2026


Lantern Pharma Earnings release: Q2 2026

Aug 14, 2026, 9:00 AM EDT - 24 days ago

Lantern Pharma Earnings release: Q2 2026


Lantern Pharma Slides: Q2 2026

Aug 14, 2026, 9:00 AM EDT - 24 days ago

Lantern Pharma Slides: Q2 2026


Lantern Pharma launches ZetaOmics computational-biology module

2026-07-08T11:35:47.000Z - 2 months ago

Lantern Pharma launches ZetaOmics computational-biology module


Lantern Pharma Slides: Corporate presentation

Jul 1, 2026, 7:00 AM EDT - 2 months ago

Lantern Pharma Slides: Corporate presentation


Lantern Pharma Registration statement: Registration filing

Jun 12, 2026, 8:00 AM EDT - 2 months ago

Lantern Pharma Registration statement: Registration filing


Lantern Pharma Earnings release: Q1 2026

May 15, 2026, 4:00 PM EDT - 3 months ago

Lantern Pharma Earnings release: Q1 2026


Lantern Pharma Quarterly report: Q1 2026

May 15, 2026, 4:00 PM EDT - 3 months ago

Lantern Pharma Quarterly report: Q1 2026


Lantern Pharma unveils roadmap for withZeta.ai

2026-05-07T19:23:32.000Z - 4 months ago

Lantern Pharma unveils roadmap for withZeta.ai


Lantern Pharma Transcript: Investor update

Apr 30, 2026, 8:30 AM EDT - 4 months ago

Lantern Pharma Transcript: Investor update


Lantern Pharma announces expansion of predictBBB.ai into LQM

2026-04-29T13:54:13.000Z - 4 months ago

Lantern Pharma announces expansion of predictBBB.ai into LQM


Lantern Pharma announces public demonstration of withZeta.ai

2026-04-24T11:56:40.000Z - 4 months ago

Lantern Pharma announces public demonstration of withZeta.ai


Lantern Pharma launches withZeta.ai

2026-04-14T12:46:58.000Z - 4 months ago

Lantern Pharma launches withZeta.ai


Lantern Pharma to host live demonstration of withZeta.ai

2026-04-02T12:15:05.000Z - 5 months ago

Lantern Pharma to host live demonstration of withZeta.ai


Lantern Pharma Earnings Call Transcript: Q4 2025

Mar 30, 2026, 4:30 PM EDT - 5 months ago

Lantern Pharma Earnings Call Transcript: Q4 2025


Lantern Pharma Annual report: Q4 2025

Mar 30, 2026, 4:30 PM EDT - 5 months ago

Lantern Pharma Annual report: Q4 2025


Lantern Pharma Earnings release: Q4 2025

Mar 30, 2026, 4:30 PM EDT - 5 months ago

Lantern Pharma Earnings release: Q4 2025


Lantern Pharma Slides: Q4 2025

Mar 30, 2026, 4:30 PM EDT - 5 months ago

Lantern Pharma Slides: Q4 2025


Lantern Pharma Slides: Corporate presentation

Mar 30, 2026, 7:00 AM EDT - 5 months ago

Lantern Pharma Slides: Corporate presentation


Lantern Pharma Slides: corporate presentation

Jan 8, 2026, 7:00 AM EST - 8 months ago

Lantern Pharma Slides: corporate presentation


Lantern Pharma Transcript: Status Update

Nov 20, 2025, 4:30 PM EST - 9 months ago

Lantern Pharma Transcript: Status Update


Lantern Pharma Earnings Call Transcript: Q3 2025

Nov 13, 2025, 9:00 AM EST - 9 months ago

Lantern Pharma Earnings Call Transcript: Q3 2025


Lantern Pharma Earnings release: Q3 2025

Nov 13, 2025, 9:00 AM EST - 9 months ago

Lantern Pharma Earnings release: Q3 2025


Lantern Pharma Quarterly report: Q3 2025

Nov 13, 2025, 9:00 AM EST - 9 months ago

Lantern Pharma Quarterly report: Q3 2025


Lantern Pharma Slides: Q3 2025

Nov 13, 2025, 9:00 AM EST - 9 months ago

Lantern Pharma Slides: Q3 2025


Lantern Pharma Transcript: 2025 ThinkEquity Conference

Oct 30, 2025, 11:30 AM EDT - 10 months ago

Lantern Pharma Transcript: 2025 ThinkEquity Conference


Lantern Pharma Transcript: Investor Update

Aug 26, 2025, 4:15 PM EDT - 1 year ago

Lantern Pharma Transcript: Investor Update


Lantern Pharma Earnings release: Q2 2025

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Lantern Pharma Earnings release: Q2 2025


Lantern Pharma Quarterly report: Q2 2025

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Lantern Pharma Quarterly report: Q2 2025


Lantern Pharma Proxy statement: Proxy Filing

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Lantern Pharma Proxy statement: Proxy Filing


Lantern Pharma Proxy statement: Proxy Filing

Jul 28, 2025, 8:00 AM EDT - 1 year ago

Lantern Pharma Proxy statement: Proxy Filing


Lantern Pharma Earnings Call Transcript: Q1 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Lantern Pharma Earnings Call Transcript: Q1 2025


Lantern Pharma Quarterly report: Q1 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Lantern Pharma Quarterly report: Q1 2025


Lantern Pharma Earnings release: Q1 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Lantern Pharma Earnings release: Q1 2025


Lantern Pharma Slides: Q1 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Lantern Pharma Slides: Q1 2025


Lantern Pharma Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Lantern Pharma Earnings Call Transcript: Q4 2024


Lantern Pharma Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Lantern Pharma Annual report: Q4 2024


Lantern Pharma Earnings release: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Lantern Pharma Earnings release: Q4 2024


Lantern Pharma Slides: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Lantern Pharma Slides: Q4 2024


BioTechHealthX
BioTechHealthX Sep. 6 at 6:24 PM
$ABSI $LTRN $RXRX $SDGR $SOPH Discover 10 affordable medical AI stocks using artificial intelligence to transform drug development, cancer detection, diagnostics and patient care. https://biotechhealthx.com/biotech-news/10-best-cheap-ai-medicine-stocks-to-buy-now/
0 · Reply
AtariLynx
AtariLynx Sep. 6 at 11:39 AM
$LTRN LET’S GO LANTERN PHARMA! https://youtu.be/CTXYBZXHIzk?is=ZxfxoklIYoiKTUSV
1 · Reply
focafoca99
focafoca99 Sep. 5 at 9:42 PM
$LTRN will be featured on New to The Street broadcast at 6:30 PM ET on Sep 5.
0 · Reply
AtariLynx
AtariLynx Sep. 4 at 8:04 PM
$LTRN closed green. Now green until 2027 😀💪🏻
1 · Reply
AtariLynx
AtariLynx Sep. 4 at 3:28 PM
$LTRN nooooo! I was there when it dropped to 1.19 and no one spoke about R/S. We were all confident that it would rise again and so it did.
1 · Reply
BabetteCH
BabetteCH Sep. 4 at 2:19 PM
$LTRN let‘s reverse-split 🤣
0 · Reply
BabetteCH
BabetteCH Sep. 4 at 7:25 AM
$LTRN @AtariLynx ask him why mgmt does not invest with own money? Not buy open market shares? Thks. 😉
1 · Reply
AtariLynx
AtariLynx Sep. 4 at 7:22 AM
$LTRN I spoke to him again. He said tell Babette that a successful CEO must be prepared and integrated in all areas. He should talk about sports, engines, cookies, travelling, matters of the heart etc etc with the same ease he uses to speak about Lantern’s projects. I'm sure he won't disappoint us!
0 · Reply
BabetteCH
BabetteCH Sep. 4 at 5:27 AM
$LTRN @AtariLynx he didn‘t have time for you, he had to do a new interview with „new to the street“, with words like „could“, „think“, „propably“ - same bs as every time. And on top he had to like EVERY LinkedIn post in the world! So no time for you and business/BP-Deals…
0 · Reply
DarthVestor
DarthVestor Sep. 4 at 12:02 AM
$LTRN pOS stock. POS CEO.
0 · Reply
AtariLynx
AtariLynx Sep. 3 at 9:18 PM
$LTRN just spoked to Panna. He said tell Babette to be patient because the most painful things are the most beautiful.
1 · Reply
BabetteCH
BabetteCH Sep. 3 at 8:03 PM
$LTRN again. 7 steps down! Reverse-split is very close. Empery will love it 🎉🤣😉
0 · Reply
AtariLynx
AtariLynx Sep. 3 at 7:02 PM
$LTRN $LTRN 222k shares traded today. Better than other times.
0 · Reply
BabetteCH
BabetteCH Sep. 3 at 5:29 PM
$LTRN 🤣😂
0 · Reply
AtariLynx
AtariLynx Sep. 3 at 4:01 PM
$LTRN reduce your avg! 💪🏻💪🏻💪🏻
1 · Reply
BabetteCH
BabetteCH Sep. 3 at 3:41 PM
$LTRN reverse-split closer and closer…
0 · Reply
Mike_Rotsch
Mike_Rotsch Sep. 3 at 3:33 PM
$LTRN In at 1.90. This one's ready to as well.
0 · Reply
BabetteCH
BabetteCH Sep. 3 at 4:02 AM
$LTRN panna on LinkedIn: „Throughout September, we will share more about pediatric cancer, the patients and families affected by these diseases, and the work underway to develop potential new options“. But still no webcast 🥲
0 · Reply
SevenPhigs27
SevenPhigs27 Sep. 2 at 8:34 PM
$LTRN The beauty of the stockmarket is that you can still exit with capital if your perception changes. Sometimes I can't understand what people see when the whole market has been down. I don't see anyone saying it sucks that they only have around 15-17MM shares fully diluted outstanding compared to other similar companies that over 250MM, 500MM, etc. Then you see a post with a correlation to Briarcell? It's quite comical.
1 · Reply
BabetteCH
BabetteCH Sep. 2 at 7:29 PM
$LTRN i don‘t trust this mgmt any more. Bad communication, never direct insider buying, no news about lo-300 (just blablabla)…!
1 · Reply
BabetteCH
BabetteCH Sep. 2 at 3:24 PM
$LTRN soon reverse split - great job 🥲
1 · Reply
AtariLynx
AtariLynx Sep. 2 at 6:14 AM
$LTRN interesting to see their avg price. Last chance to buy at this discount price. Obviously it’s just my opinion. https://hedgefollow.com/stocks/LTRN
0 · Reply